高级检索

治疗肝细胞癌的研究性新药namodenoson有关物质分析方法的建立与验证

Establishment and validation of an analytical method for related substances in namodenoson, an investigational new drug for hepatocellular carcinoma

  • 摘要: 建立并验证用于测定namodenoson中有关物质的高效液相色谱法。取紫外光照射降解溶液与碱降解溶液等体积混合,作为系统适用性溶液,可涵盖潜在的主要有关物质。采用Luna-C18色谱柱(250 mm × 4.6 mm,5 μm),以2 mmol/L磷酸二氢钾水溶液(用磷酸调节pH至2.5)-乙腈(90∶10)为流动相A、乙腈为流动相B,进行梯度洗脱,检测波长275 nm;实现了各有关物质峰的完全分离。方法学验证结果显示,namodenoson及其有关物质峰的分离度均符合要求;namodenoson在0.1~10 μg/mL范围内线性良好(r=0.9989),检测限与定量限分别为0.01和0.05 μg/mL。强制降解实验样本分析进一步表明该方法专属性强,物料平衡率良好(96.1%~99.1%)。本研究建立的方法稳定、可靠且耐用性良好,可为namodenoson的质量标准建立、稳定性研究及生产工艺优化提供参考。

     

    Abstract: This study aimed to establish and validate a high-performance liquid chromatography (HPLC) method for the determination of related substances in namodenoson. A system suitability solution was prepared by mixing equal volumes of the UV-degraded solution and the alkali-degraded solution, which could cover the potential major related substances. Separation was performed on a Luna C18 column (250 mm × 4.6 mm, 5 μm) using gradient elution with mobile phase A (a mixture of 2 mmol/L potassium dihydrogen phosphate solution adjusted to pH 2.5 with phosphoric acid and acetonitrile, 90∶10) and mobile phase B (acetonitrile). The detection wavelength was set at 275 nm, and complete separation of all related substance peaks was obtained. Method validation results demonstrated that the resolution between namodenoson and its related substances, as well as that among all related substances, met the requirements. Namodenoson exhibited good linearity over the range of 0.1–10 μg/mL (r = 0.9989), with a limit of detection (LOD) of 0.01 μg/mL and a limit of quantitation (LOQ) of 0.05 μg/mL. Analysis of forced degradation samples further demonstrated the excellent specificity of the method, with satisfactory mass balance values (96.1%–99.1%). The method established is stable, reliable, and robust, and can serve as a reference for the establishment of quality standards, stability studies, and manufacturing process optimization of namodenoson.

     

/

返回文章
返回